In this letter, we introduce a novel refractive index sensor based on gradient grating period guided-mode resonance (GGP-GMR). Rather than a constant grating period, as in typical GMR, GGP-GMR comprises a grating period varying in increments of 2 nm. For grating variation from 386 to 392 nm, a detection range of 0.109 RIU with a bulk sensitivity of 1433.7 μm/RIU and theoretical and experimental detection limits of 5.58 × 10-3and 10-2RIU, respectively, can be achieved. Several tactics that can be readily adopted are suggested to improve the limit of detection by an order of 10-4RIU, sufficient for detecting many clinically relevant biomarkers. The readout system requires a narrow band of light and a simple charge-coupled device combined with the compact design of the GGP-GMR sensor, which eases the miniaturization of the system for handheld devices as well as its integration with smartphones.
No takes yet. Share an insight, caveat, or question.
Hsiung et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: